ANAPLASTIC OLIGOASTROCYTOMA
Clinical trials for ANAPLASTIC OLIGOASTROCYTOMA explained in plain language.
Never miss a new study
Get alerted when new ANAPLASTIC OLIGOASTROCYTOMA trials appear
Sign up with your email to follow new studies for ANAPLASTIC OLIGOASTROCYTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to stall deadly brain tumors
Disease control Recruiting nowThis study tests a new way to deliver a cancer drug directly to the brain along with repeat radiation for people whose aggressive brain tumors have come back. The drug, cetuximab, targets a protein common on these cancer cells. The goal is to see if this combination can stop tumo…
Matched conditions: ANAPLASTIC OLIGOASTROCYTOMA
Phase: PHASE2 • Sponsor: Northwell Health • Aim: Disease control
Last updated May 17, 2026 08:01 UTC
-
New combo therapy targets aggressive brain tumors in phase 2 trial
Disease control Recruiting nowThis study tests a more intense treatment for a fast-growing type of brain cancer called IDH wildtype glioma. It combines higher doses of radiation with the chemotherapy drug temozolomide to try to stop the tumor from growing longer. The trial will enroll 40 adults with this spec…
Matched conditions: ANAPLASTIC OLIGOASTROCYTOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:53 UTC